Clinical expression of LRRK2 G2019S mutations in the elderly. - Wikidata - awgldk - TriplyDB

Clinical expression of LRRK2 G2019S mutations in the elderly.

Clinical expression of LRRK2 G2019S mutations in the elderly.

http://www.wikidata.org/entity/Q34300290

about

Substantia nigra hyperechogenicity with LRRK2 G2019S mutations Gender differences in the risk of familial parkinsonism: beyond LRRK2?Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.LRRK2: cause, risk, and mechanism.Motor signs in the prodromal phase of Parkinson's disease.Cellular processes associated with LRRK2 function and dysfunction Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.Inventory of real world data sources in Parkinson's disease.Cognitive changes in prodromal Parkinson's disease: A review.

P2860

Q34861140-AFAE2B95-A27B-4C2B-AA4B-3E4E76A3A437 Q35037102-312DA448-FF7D-490B-8CC8-9195D0E102F9 Q35148581-6FF170ED-DF19-4E90-B2B1-B45C6AB6D231 Q37591146-1125889E-9A4A-41C4-9778-37C0B894EFD4 Q37635000-D46E5576-544D-4B8D-A41B-C8E7236454E6 Q37995956-66A57BEA-F414-477C-A23A-E3D60468C956 Q38433725-AEED3F75-3DF6-405C-B827-23339B6E4053 Q42495787-8908B5CE-A423-4712-8EC1-B2D17B8A0A4D Q47101523-16658527-A116-4D6B-9F4D-6CFB6E1C6D7A Q47860019-7FBC3E58-5380-4B20-855F-EC5A82DA380F

P2860

Clinical expression of LRRK2 G2019S mutations in the elderly.

http://www.wikidata.org/entity/Q34300290

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical expression of LRRK2 G2019S mutations in the elderly.

@ast

Clinical expression of LRRK2 G2019S mutations in the elderly.

@en

Clinical expression of LRRK2 G2019S mutations in the elderly.

@nl

type

label

Clinical expression of LRRK2 G2019S mutations in the elderly.

@ast

Clinical expression of LRRK2 G2019S mutations in the elderly.

@en

Clinical expression of LRRK2 G2019S mutations in the elderly.

@nl

prefLabel

Clinical expression of LRRK2 G2019S mutations in the elderly.

@ast

Clinical expression of LRRK2 G2019S mutations in the elderly.

@en

Clinical expression of LRRK2 G2019S mutations in the elderly.

@nl

P1433

Q34300290-EA8B93A9-5E99-4565-B0C2-524816EA60F2

P1476

Q34300290-A178AA5B-8B04-4AC9-BD4E-81B9D573CDA6

P2093

Q34300290-1C50D171-BB46-444A-8C5E-0CE495C25988

Q34300290-2830CB80-827F-422E-837A-65667927A34B

Q34300290-356584AE-AFD4-46E7-8B41-C51F8113FDC8

Q34300290-35E55D5F-7AC9-465F-B24B-3AC494E46C3A

Q34300290-4B3EEC43-CF06-47DF-9E40-CDA7141BBE80

Q34300290-601BEC13-D31F-415B-B66F-FB4C4C16D7D0

Q34300290-BA0BE1E2-D4E6-47E5-833B-153543FF333D

P2860

Q34300290-05E7F3BE-7F95-43E9-B1F5-4A9352CAD0BB

Q34300290-0949C77D-8775-48EE-A4EC-E39C305AC57F

Q34300290-0DB705D5-935E-45C1-8796-9FC10056C295

Q34300290-159FE216-4780-40F3-B767-4F5682A896E2

Q34300290-1C806F79-2F02-4D39-BD16-D91197539B87

Q34300290-1F1BB9A3-1ADF-4F4C-9CD0-C15737D49199

Q34300290-20CB9D40-BA45-4639-AAD5-879D95064CE9

Q34300290-3D59FB5F-E453-49D6-8EB8-DB4C7AB7BD28

Q34300290-50C9AFEC-1B0E-49B5-B03D-489B26C4F332

Q34300290-53A518FB-BFD8-4C61-B96E-958BEA6D035D

P304

Q34300290-4E873A07-7F15-4842-A724-4B15D019122C

P31

Q34300290-DB9EFCB1-5357-4E78-A019-D33AA22F2E8A

P356

Q34300290-69729A54-1954-4C14-BA59-549673B515D4

P407

Q34300290-436826A1-AF13-4C00-B9BC-19EDDBFE7029

P433

Q34300290-7E349CBA-D472-44A9-80CC-84156F7127BE

P478

Q34300290-8B413D1C-A1AC-4247-84B1-0E3E54A2B1CE

P50

Q34300290-131B06D6-A4EB-4411-90D1-BB360B46F03D

Q34300290-C743B378-483D-40C3-BE80-658FFA0E5CEC

P577

Q34300290-4CA0A0E4-B7CD-4A3D-A4E0-23E193DBFCD9

P5875

Q34300290-2E779895-A8C5-4157-B03C-DAB42A3C80C5

P698

Q34300290-507E04B9-5D7F-4E81-AAA1-E332C23D5CB1

P932

Q34300290-F2D581B4-10E1-4470-891D-C4A278344F4A

P356

P1433

Movement Disorders

P1476

Clinical expression of LRRK2 G2019S mutations in the elderly.

@en

P2093

Amy E Sanders

http://www.w3.org/2001/XMLSchema#string

Cuiling Wang

http://www.w3.org/2001/XMLSchema#string

Laurie J Ozelius

http://www.w3.org/2001/XMLSchema#string

Marta San Luciano

http://www.w3.org/2001/XMLSchema#string

Mindy Katz

http://www.w3.org/2001/XMLSchema#string

Molly E Zimmerman

http://www.w3.org/2001/XMLSchema#string

Susan B Bressman

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

A common LRRK2 mutation in idiopathic Parkinson's disease

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

The Clinical Dementia Rating (CDR): current version and scoring rules

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

The premotor phase of Parkinson's disease.

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

P304

2571-2576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23330

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Richard B. Lipton

Rachel Saunders-Pullman

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45709870

http://www.w3.org/2001/XMLSchema#string

P698

20721910

http://www.w3.org/2001/XMLSchema#string

P932

2978804

http://www.w3.org/2001/XMLSchema#string